CASI Pharmaceuticals, Inc.
CASIF
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.33M
Close$
Share Statistics
| Market cap | $2.33 Million |
|---|---|
| Enterprise Value | $16.50 Million |
| Dividend Yield | $NaN (NaN%) |
| Earnings per Share | $- |
| Beta | - |
| Outstanding Shares | - |
Return
| Return on Equity | 172.70% |
|---|---|
| Return on Assets | -201.86% |
| Return on Invested Capital | 284.36% |
Valuation & Multiples
| P/E Ratio | - |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 0.61 |
| Enterprise Value to EBIT | -0.39 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 1.14 |
| Debt to Equity | -0.66 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About CASI Pharmaceuticals Inc
214 employees
CEO: Wei-Wu He CASI Pharmaceuticals, Inc. is a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products in China, the United States, and throughout the world. The Company is focused on...